GlassScriptPhysician profile
Jolene K Johnson
NPI 1568485407
$10,150.33
in general payments reported to CMS, 2019-2025
46 companies · $57.57 in 2025
The $57.57 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,836 · 2020: $1,691 · 2021: $1,685 · 2022: $1,423 · 2023: $1,080 · 2024: $378 · 2025: $57.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $2,493.67 | 2019-2022 | |
| Novo Nordisk INC | $1,822.72 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $688.12 | 2019-2023 | Mounjaro, Jardiance, Humulin |
| Amgen INC. | $627.26 | 2019-2022 | |
| Abbott Laboratories | $528.87 | 2019-2024 | Freestyle Libre 3, Freestyle Libre |
| Dexcom, INC. | $454.17 | 2019-2022 | |
| Radius Health, INC. | $417.40 | 2019-2024 | Tymlos |
| Corcept Therapeutics | $392.17 | 2019-2023 | Korlym |
| Abbvie INC. | $260.23 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.97 | 2019-2023 | Trijardy Xr, Synjardy |
| Alexion Pharmaceuticals, INC. | $173.16 | 2020-2024 | Strensiq |
| Xeris Pharmaceuticals, INC. | $162.54 | 2021-2023 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $138.27 | 2019-2022 | |
| Medtronic, INC. | $129.89 | 2021-2023 | Minimed 770g |
| Insulet Corporation | $129.78 | 2022-2024 | Omnipod |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jolene Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.